Identification and regulation of protein components of the apolipoprotein B mRNA editing enzyme - A complex event

Trends in Cardiovascular Medicine

Volumn 12, Issue 7, 2002, Pages 311-317

  Anant, Shrikant ^a   Davidson, Nicholas O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; MESSENGER RNA; PROTEIN ABBP 2; PROTEIN ARCD 1; PROTEIN CUGBP2; PROTEIN GRY RBP; UNCLASSIFIED DRUG;

ENZYME MODIFICATION; GENE EXPRESSION; HUMAN; INTESTINE CELL; LIVER CELL; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM; REVIEW; RNA EDITING; TRANSCRIPTION REGULATION;

ANIMALS; CYTIDINE DEAMINASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTESTINE, SMALL; LIPOPROTEINS; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 0036811663     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(02)00180-9     Document Type: Review

References (57)

1. Anant S., Davidson N.O. An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1. binding of Apobec-1 to this motif in the 3′ untranslated region of c-myc increases mRNA stability Mol Cell Biol. 20:2000;1982-1992.
2. Anant S., Davidson N.O. Molecular mechanisms of apolipoprotein B mRNA editing. Curr Opin Lipidol. 12:2001;159-165.
3. Anant S., Henderson J.O., Mukhopadhyay D.et al. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor J Biol Chem. 276:2001;47,338-47,351. a.
4. Anant S., MacGinnitie A.J., Davidson N.O. Apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein. J Biol Chem. 270:1995;14,762-14,767.
5. Anant S., Mukhopadhyay D., Sankaranand V.et al. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing. Am J Physiol Cell Physiol. 281:2001;C1904-C1916. b.
6. Anant S., Yu H., Davidson N.O. Evolutionary origins of the mammalian apolipoprotein B RNA editing enzyme, apobec-1. structural homology inferred from analysis of a cloned chicken small intestinal cytidine deaminase Biol Chem. 379:1998;1075-1081.
7. Backus J.W., Smith H.C. Three distinct RNA sequence elements are required for efficient apolipoprotein B (apoB) RNA editing in vitro. Nucleic Acids Res. 20:1992;6007-6014.
8. Blanc V., Henderson J.O., Kennedy S., Davidson N.O. Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1, and complementation of C to U RNA-editing activity. J Biol Chem. 276:2001;46,386-46,393. a.
9. Blanc V., Navaratnam N., Henderson J.O.et al. Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing. J Biol Chem. 276:2001;10,272-10,283. b.
10. Cappione A.J., French B.L., Skuse G.R. A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors. Am J Hum Genet. 60:1997;305-312.
11. Chan L., Chang B.H., Liao W.et al. Apolipoprotein B. from editosome to proteasome Recent Prog Horm Res. 55:2000;93-125.
12. Chen C.Y., Gherzi R., Ong S.E.et al. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell. 107:2001;451-464.
13. Chester A., Scott J., Anant S., Navaratnam N. RNA editing. cytidine to uridine conversion in apolipoprotein B mRNA Biochim Biophys Acta. 1494:2000;1-13.
14. Chou M.Y., Rooke N., Turck C.W., Black D.L. hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells. Mol Cell Biol. 19:1999;69-77.
15. Dance G.S., Sowden M.P., Cartegni L.et al. Two proteins essential for apolipoprotein B mRNA editing are expressed from a single gene through alternative splicing. J Biol Chem. 277:2002;12,703-12,709.
16. Davidson N.O., Anant S., MacGinnitie A.J. Apolipoprotein B messenger RNA editing. insights into the molecular regulation of post-transcriptional cytidine deamination Curr Opin Lipidol. 6:1995;70-74.
17. Davidson N.O., Shelness G.S. Apolipoprotein B. mRNA editing, lipoprotein assembly, and presecretory degradation Annu Rev Nutr. 20:2000;169-193.
18. Driscoll D.M., Lakhe-Reddy S., Oleksa L.M., Martinez D. Induction of RNA editing at heterologous sites by sequences in apolipoprotein B mRNA. Mol Cell Biol. 13:1993;7288-7294.
19. Greeve J., Altkemper I., Dieterich J.H.et al. Apolipoprotein B mRNA editing in 12 different mammalian species. hepatic expression is reflected in low concentrations of apoB- containing plasma lipoproteins J Lipid Res. 34:1993;1367-1383.
20. Greeve J., Jona V.K., Chowdhury N.R.et al. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits. J Lipid Res. 37:1996;2001-2017.
21. Greeve J., Lellek H., Rautenberg P., Greten H. Inhibition of the apolipoprotein B mRNA editing enzyme-complex by hnRNP C1 protein and 40S hnRNP complexes. Biol Chem. 379:1998;1063-1073.
22. Henderson J.O., Blanc V., Davidson N.O. Isolation, characterization and developmental regulation of the human apobec-1 complementation factor (ACF) gene. Biochim Biophys Acta. 1522:2001;22-30.
23. Hersberger M., Innerarity T.L. Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing. J Biol Chem. 273:1998;9435-9442.
24. Hirano K., Young S.G., Farese R.V. Jr. et al. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J Biol Chem. 271:1996;9887-9890.
25. Inui Y., Hausman A.M., Nanthakumar N.et al. Apolipoprotein B messenger RNA editing in rat liver. developmental and hormonal modulation is divergent from apolipoprotein A-IV gene expression despite increased hepatic lipogenesis J Lipid Res. 33:1992;1843-1856.
26. Kozarsky K.F., Bonen D.K., Giannoni F.et al. Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits. Hum Gene Ther. 7:1996;943-957.
27. Lau P.P., Villanueva H., Kobayashi K.et al. A DNAJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. J Biol Chem. 276:2001;46,445-46,452.
28. Lau P.P., Zhu H.J., Nakamuta M., Chan L. Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing. J Biol Chem. 272:1997;1452-1455.
29. Lellek H., Kirsten R., Diehl I.et al. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex. J Biol Chem. 275:2000;19,848-19,856.
30. Liao W., Hong S.H., Chan B.H.et al. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family. Biochem Biophys Res Commun. 260:1999;398-404.
31. Lu X., Timchenko N.A., Timchenko L.T. Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy. Hum Mol Genet. 8:1999;53-60.
32. MacGinnitie A.J., Anant S., Davidson N.O. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity. J Biol Chem. 270:1995;14,768-14,775.
33. Mehta A., Driscoll D.M. Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing. RNA. 8:2002;69-82.
34. Mehta A., Kinter M.T., Sherman N.E., Driscoll D.M. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol Cell Biol. 20:2000;1846-1854.
35. Min H., Turck C.W., Nikolic J.M., Black D.L. A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer. Genes Dev. 11:1997;1023-1036.
36. Morrison J.R., Paszty C., Stevens M.E.et al. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism. Proc Natl Acad Sci USA. 93:1996;7154-7159.
37. Mourelatos Z., Abel L., Yong J.et al. SMN interacts with a novel family of hnRNP and spliceosomal proteins. EMBO J. 20:2001;5443-5452.
38. Mukhopadhyay D., Anant S., Lee R.M.et al. C→U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme. Am J Hum Genet. 70:2002;38-50.
39. Nakamuta M., Oka K., Krushkal J.et al. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec. 1(and related nucleoside/nucleotide deaminases. J Biol Chem 270):1995;13,042-13,056.
40. Navaratnam N., Bhattacharya S., Fujino T.et al. Evolutionary origins of apoB mRNA editing. catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site Cell. 81:1995;187-195.
41. Navaratnam N., Fujino T., Bayliss J.et al. Escherichia coli cytidine deaminase provides a molecular model for apoB RNA editing and a mechanism for RNA substrate recognition. J Mol Biol. 275:1998;695-714.
42. Navaratnam N., Shah R., Patel D.et al. Apolipoprotein B mRNA editing is associated with UV crosslinking of proteins to the editing site. Proc Natl Acad Sci USA. 90:1993;222-226.
43. Powell-Braxton L., Veniant M., Latvala R.D.et al. A mouse model of human familial hypercholesterolemia. markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet Nat Med. 4:1998;934-938.
44. Richardson N., Navaratnam N., Scott J. Secondary structure for the apolipoprotein B mRNA editing site. AU-binding proteins interact with a stem loop. J Biol Chem. 273:1998;31,707-31,717.
45. Ross J. mRNA stability in mammalian cells. Microbiol Rev. 59:1995;423-450.
46. Schock D., Kuo S.R., Steinburg M.F.et al. An auxiliary factor containing a 240-kDa protein complex is involved in apolipoprotein B RNA editing. Proc Natl Acad Sci USA. 93:1996;1097-1102.
47. Shah R.R., Knott T.J., Legros J.E.et al. Sequence requirements for the editing of apolipoprotein B mRNA. J Biol Chem. 266:1991;16,301-16,304.
48. Smith H.C., Kuo S.R., Backus J.W.et al. In vitro apolipoprotein B mRNA editing. identification of a 27S editing complex Proc Natl Acad Sci USA. 88:1991;1489-1493.
49. Sowden M.P., Ballatori N., Jensen K.L.et al. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S. identification of intracellular domains containing active and inactive editing factors J Cell Sci. 115:2002;1027-1039.
50. Teng B., Burant C.F., Davidson N.O. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science. 260:1993;1816-1819.
51. Teng B., Davidson N.O. Evolution of intestinal apolipoprotein B mRNA editing. Chicken apolipoprotein B mRNA is not edited, but chicken enterocytes contain in vitro editing enhancement factor(s). J Biol Chem. 267:1992;21,265-21,272.
52. Timchenko L.T., Timchenko N.A., Caskey C.T., Roberts R. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats. implications for myotonic dystrophy Hum Mol Genet. 5:1996;115-121.
53. Yamanaka S., Balestra M.E., Ferrell L.D.et al. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci USA. 92:1995;8483-8487.
54. Yamanaka S., Poksay K.S., Balestra M.E.et al. Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed. J Biol Chem. 269:1994;21,725-21,734.
55. Yang Y., Kovalski K., Smith H.C. Partial characterization of the auxiliary factors involved in apolipoprotein B mRNA editing through APOBEC-1 affinity chromatography. J Biol Chem. 272:1997;27,700-27,706.
56. Young S.G. Recent progress in understanding apolipoprotein B. Circulation. 82:1990;1574-1594.
57. Yu M., Haslam R.H., Haslam D.B. HEDJ, an Hsp40 co-chaperone localized to the endoplasmic reticulum of human cells. J Biol Chem. 275:2000;24,984-24,992.